Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
Clicks: 104
ID: 270480
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
104 views
13 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #748 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
In a prospective, observational cohort, propensity-adjusted mortality was decreased in patients with carbapenem-resistant Enterobacteriaceae infections started
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (16 words).
Try re-searching for a better abstract.
| Reference Key |
david2018clinicalcolistin
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | van Duin, David;Lok, Judith J;Earley, Michelle;Cober, Eric;Richter, Sandra S;Perez, Federico;Salata, Robert A;Kalayjian, Robert C;Watkins, Richard R;Doi, Yohei;Kaye, Keith S;Fowler, Vance G;Paterson, David L;Bonomo, Robert A;Evans, Scott;Antibacterial Resistance Leadership Group; |
| Journal | clinical infectious diseases |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.